ArticleJournal of the Canadian Association of Gastroenterology2025

Assessing the role of ustekinumab dose escalation in Crohn's disease patients with loss of response: an observational study.

Davide De Marco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.